{"id":56431,"date":"2023-05-02T14:03:11","date_gmt":"2023-05-02T12:03:11","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/alto-neuroscience-announces-ceo-amit-etkin-m-d-ph-d-named-as-an-entrepreneur-of-the-year-2023-bay-area-award-finalist\/"},"modified":"2023-05-02T14:03:11","modified_gmt":"2023-05-02T12:03:11","slug":"alto-neuroscience-announces-ceo-amit-etkin-m-d-ph-d-named-as-an-entrepreneur-of-the-year-2023-bay-area-award-finalist","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/alto-neuroscience-announces-ceo-amit-etkin-m-d-ph-d-named-as-an-entrepreneur-of-the-year-2023-bay-area-award-finalist\/","title":{"rendered":"Alto Neuroscience Announces CEO Amit Etkin, M.D., Ph.D., Named as an Entrepreneur Of The Year\u00ae 2023 Bay Area Award Finalist"},"content":{"rendered":"
\n

\nEntrepreneur Of The Year celebrates ambitious entrepreneurs who are building bolder futures<\/i><\/p>\n

LOS ALTOS, Calif.–(BUSINESS WIRE)–Alto Neuroscience today announced that Amit Etkin, M.D., Ph.D., founder and chief executive officer, was named an Entrepreneur Of The Year\u00ae<\/sup> 2023 Bay Area Award finalist. Now in its 37th year, Entrepreneur Of The Year by Ernst & Young (EY) is one of the preeminent competitive business awards for transformative entrepreneurs and leaders of high-growth companies who are building a more equitable, sustainable, and prosperous world for all.<\/p>\n

<\/a><\/p>\n

\nDr. Etkin was selected by an independent panel of judges based on his demonstration of building long-term value through entrepreneurial spirit, purpose, growth, and impact, among other core contributions and attributes.<\/p>\n

\n\u201cI am honored to be recognized as a finalist for EY\u2019s Entrepreneur Of The Year alongside other prominent business leaders in the Bay Area,\u201d said Amit Etkin, M.D., Ph.D., founder and chief executive officer of Alto Neuroscience. \u201cDeparting from my tenured position at Stanford to launch a company felt like quite a leap, but has since proven to be well worth the risk. I\u2019m incredibly proud of all we have accomplished to advance new medicines in mental health, and thankful to our dedicated team that has put in the work to make Alto\u2019s vision a reality.\u201d<\/p>\n

\nThe Entrepreneur Of The Year program has recognized more than 11,000 entrepreneurs throughout the US since its inception in 1986, and it has grown to recognize business leaders across 145 cities in over 60 countries around the world.<\/p>\n

\nAbout Entrepreneur Of The Year<\/b>\u00ae<\/sup><\/p>\n

\nEntrepreneur Of The Year\u00ae<\/sup> is the world\u2019s most prestigious business awards program for unstoppable entrepreneurs. These visionary leaders deliver innovation, growth and prosperity that transform our world. The program engages entrepreneurs with insights and experiences that foster growth. It connects them with their peers to strengthen entrepreneurship around the world. Entrepreneur Of The Year is the first and only truly global awards program of its kind. It celebrates entrepreneurs through regional and national awards programs in more than 145 cities in over 60 countries. National Overall Award winners go on to compete for the EY World Entrepreneur Of The Year\u2122 title. Visit ey.com\/us\/eoy<\/a>.<\/p>\n

\nAbout EY<\/b><\/p>\n

\nEY exists to build a better working world, helping create long-term value for clients, people and society and build trust in the capital markets. Enabled by data and technology, diverse EY teams in over 150 countries provide trust through assurance and help clients grow, transform and operate. Working across assurance, consulting, law, strategy, tax and transactions, EY teams ask better questions to find new answers for the complex issues facing our world today.<\/p>\n

\nEY refers to the global organization, and may refer to one or more, of the member firms of Ernst & Young Global Limited, each of which is a separate legal entity. Ernst & Young Global Limited, a UK company limited by guarantee, does not provide services to clients. Information about how EY collects and uses personal data and a description of the rights individuals have under data protection legislation are available via ey.com\/privacy. EY member firms do not practice law where prohibited by local laws. For more information about our organization, please visit ey.com<\/a>.<\/p>\n

\nAbout Alto Neuroscience<\/b><\/p>\n

\nAlto Neuroscience is pioneering precision psychiatry by developing targeted medicines to help patients get better faster. Differences in individuals\u2019 biology impact how they respond to treatment. Alto\u2019s Precision Psychiatry Platform\u2122 measures brain biomarkers by analyzing EEG activity, behavioral task performance, wearable data, genetics, and other factors to match each patient with the right Alto drug. The company\u2019s work in identifying and categorizing core domains of mental function (cognition, emotion, and sleep processes) has resulted in a multiple modality approach that supports robust drug-response predictions. Alto\u2019s clinical-stage pipeline includes first- or best-in-class novel drug candidates in depression, PTSD, and other mental health conditions, resulting in the broadest and most-advanced precision psychiatry effort. For more information, visit https:\/\/www.altoneuroscience.com<\/a> or follow us on Twitter<\/a>.<\/p>\n

Contacts<\/b> <\/p>\n

\nInvestor Contact<\/b>
Nick Smith
\n
corporate@altoneuroscience.com<\/a><\/p>\n

\nMedia Contact<\/b>
Jordann Merkert
\n
media@altoneuroscience.com<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

Entrepreneur Of The Year celebrates ambitious entrepreneurs who are building bolder futures LOS ALTOS, Calif.–(BUSINESS WIRE)–Alto Neuroscience today announced that Amit Etkin, M.D., Ph.D., founder and chief executive officer, was named an Entrepreneur Of The Year\u00ae 2023 Bay Area Award finalist. Now in its 37th year, Entrepreneur Of The Year by Ernst & Young (EY) … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-56431","6":"format-standard","7":"category-industry"},"yoast_head":"\nAlto Neuroscience Announces CEO Amit Etkin, M.D., Ph.D., Named as an Entrepreneur Of The Year\u00ae 2023 Bay Area Award Finalist - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/alto-neuroscience-announces-ceo-amit-etkin-m-d-ph-d-named-as-an-entrepreneur-of-the-year-2023-bay-area-award-finalist\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Alto Neuroscience Announces CEO Amit Etkin, M.D., Ph.D., Named as an Entrepreneur Of The Year\u00ae 2023 Bay Area Award Finalist - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"Entrepreneur Of The Year celebrates ambitious entrepreneurs who are building bolder futures LOS ALTOS, Calif.–(BUSINESS WIRE)–Alto Neuroscience today announced that Amit Etkin, M.D., Ph.D., founder and chief executive officer, was named an Entrepreneur Of The Year\u00ae 2023 Bay Area Award finalist. Now in its 37th year, Entrepreneur Of The Year by Ernst & Young (EY) ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/alto-neuroscience-announces-ceo-amit-etkin-m-d-ph-d-named-as-an-entrepreneur-of-the-year-2023-bay-area-award-finalist\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-05-02T12:03:11+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20230502005094\/en\/1266385\/21\/Alto_Neuroscience.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/alto-neuroscience-announces-ceo-amit-etkin-m-d-ph-d-named-as-an-entrepreneur-of-the-year-2023-bay-area-award-finalist\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/alto-neuroscience-announces-ceo-amit-etkin-m-d-ph-d-named-as-an-entrepreneur-of-the-year-2023-bay-area-award-finalist\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Alto Neuroscience Announces CEO Amit Etkin, M.D., Ph.D., Named as an Entrepreneur Of The Year\u00ae 2023 Bay Area Award Finalist\",\"datePublished\":\"2023-05-02T12:03:11+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/alto-neuroscience-announces-ceo-amit-etkin-m-d-ph-d-named-as-an-entrepreneur-of-the-year-2023-bay-area-award-finalist\\\/\"},\"wordCount\":700,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/alto-neuroscience-announces-ceo-amit-etkin-m-d-ph-d-named-as-an-entrepreneur-of-the-year-2023-bay-area-award-finalist\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230502005094\\\/en\\\/1266385\\\/21\\\/Alto_Neuroscience.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/alto-neuroscience-announces-ceo-amit-etkin-m-d-ph-d-named-as-an-entrepreneur-of-the-year-2023-bay-area-award-finalist\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/alto-neuroscience-announces-ceo-amit-etkin-m-d-ph-d-named-as-an-entrepreneur-of-the-year-2023-bay-area-award-finalist\\\/\",\"name\":\"Alto Neuroscience Announces CEO Amit Etkin, M.D., Ph.D., Named as an Entrepreneur Of The Year\u00ae 2023 Bay Area Award Finalist - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/alto-neuroscience-announces-ceo-amit-etkin-m-d-ph-d-named-as-an-entrepreneur-of-the-year-2023-bay-area-award-finalist\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/alto-neuroscience-announces-ceo-amit-etkin-m-d-ph-d-named-as-an-entrepreneur-of-the-year-2023-bay-area-award-finalist\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230502005094\\\/en\\\/1266385\\\/21\\\/Alto_Neuroscience.jpg\",\"datePublished\":\"2023-05-02T12:03:11+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/alto-neuroscience-announces-ceo-amit-etkin-m-d-ph-d-named-as-an-entrepreneur-of-the-year-2023-bay-area-award-finalist\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/alto-neuroscience-announces-ceo-amit-etkin-m-d-ph-d-named-as-an-entrepreneur-of-the-year-2023-bay-area-award-finalist\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/alto-neuroscience-announces-ceo-amit-etkin-m-d-ph-d-named-as-an-entrepreneur-of-the-year-2023-bay-area-award-finalist\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230502005094\\\/en\\\/1266385\\\/21\\\/Alto_Neuroscience.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230502005094\\\/en\\\/1266385\\\/21\\\/Alto_Neuroscience.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/alto-neuroscience-announces-ceo-amit-etkin-m-d-ph-d-named-as-an-entrepreneur-of-the-year-2023-bay-area-award-finalist\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Alto Neuroscience Announces CEO Amit Etkin, M.D., Ph.D., Named as an Entrepreneur Of The Year\u00ae 2023 Bay Area Award Finalist\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Alto Neuroscience Announces CEO Amit Etkin, M.D., Ph.D., Named as an Entrepreneur Of The Year\u00ae 2023 Bay Area Award Finalist - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/alto-neuroscience-announces-ceo-amit-etkin-m-d-ph-d-named-as-an-entrepreneur-of-the-year-2023-bay-area-award-finalist\/","og_locale":"en_US","og_type":"article","og_title":"Alto Neuroscience Announces CEO Amit Etkin, M.D., Ph.D., Named as an Entrepreneur Of The Year\u00ae 2023 Bay Area Award Finalist - Pharma Trend","og_description":"Entrepreneur Of The Year celebrates ambitious entrepreneurs who are building bolder futures LOS ALTOS, Calif.–(BUSINESS WIRE)–Alto Neuroscience today announced that Amit Etkin, M.D., Ph.D., founder and chief executive officer, was named an Entrepreneur Of The Year\u00ae 2023 Bay Area Award finalist. Now in its 37th year, Entrepreneur Of The Year by Ernst & Young (EY) ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/alto-neuroscience-announces-ceo-amit-etkin-m-d-ph-d-named-as-an-entrepreneur-of-the-year-2023-bay-area-award-finalist\/","og_site_name":"Pharma Trend","article_published_time":"2023-05-02T12:03:11+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20230502005094\/en\/1266385\/21\/Alto_Neuroscience.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/alto-neuroscience-announces-ceo-amit-etkin-m-d-ph-d-named-as-an-entrepreneur-of-the-year-2023-bay-area-award-finalist\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/alto-neuroscience-announces-ceo-amit-etkin-m-d-ph-d-named-as-an-entrepreneur-of-the-year-2023-bay-area-award-finalist\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Alto Neuroscience Announces CEO Amit Etkin, M.D., Ph.D., Named as an Entrepreneur Of The Year\u00ae 2023 Bay Area Award Finalist","datePublished":"2023-05-02T12:03:11+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/alto-neuroscience-announces-ceo-amit-etkin-m-d-ph-d-named-as-an-entrepreneur-of-the-year-2023-bay-area-award-finalist\/"},"wordCount":700,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/alto-neuroscience-announces-ceo-amit-etkin-m-d-ph-d-named-as-an-entrepreneur-of-the-year-2023-bay-area-award-finalist\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230502005094\/en\/1266385\/21\/Alto_Neuroscience.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/alto-neuroscience-announces-ceo-amit-etkin-m-d-ph-d-named-as-an-entrepreneur-of-the-year-2023-bay-area-award-finalist\/","url":"https:\/\/pharma-trend.com\/en\/alto-neuroscience-announces-ceo-amit-etkin-m-d-ph-d-named-as-an-entrepreneur-of-the-year-2023-bay-area-award-finalist\/","name":"Alto Neuroscience Announces CEO Amit Etkin, M.D., Ph.D., Named as an Entrepreneur Of The Year\u00ae 2023 Bay Area Award Finalist - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/alto-neuroscience-announces-ceo-amit-etkin-m-d-ph-d-named-as-an-entrepreneur-of-the-year-2023-bay-area-award-finalist\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/alto-neuroscience-announces-ceo-amit-etkin-m-d-ph-d-named-as-an-entrepreneur-of-the-year-2023-bay-area-award-finalist\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230502005094\/en\/1266385\/21\/Alto_Neuroscience.jpg","datePublished":"2023-05-02T12:03:11+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/alto-neuroscience-announces-ceo-amit-etkin-m-d-ph-d-named-as-an-entrepreneur-of-the-year-2023-bay-area-award-finalist\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/alto-neuroscience-announces-ceo-amit-etkin-m-d-ph-d-named-as-an-entrepreneur-of-the-year-2023-bay-area-award-finalist\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/alto-neuroscience-announces-ceo-amit-etkin-m-d-ph-d-named-as-an-entrepreneur-of-the-year-2023-bay-area-award-finalist\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20230502005094\/en\/1266385\/21\/Alto_Neuroscience.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20230502005094\/en\/1266385\/21\/Alto_Neuroscience.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/alto-neuroscience-announces-ceo-amit-etkin-m-d-ph-d-named-as-an-entrepreneur-of-the-year-2023-bay-area-award-finalist\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Alto Neuroscience Announces CEO Amit Etkin, M.D., Ph.D., Named as an Entrepreneur Of The Year\u00ae 2023 Bay Area Award Finalist"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/56431","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=56431"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/56431\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=56431"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=56431"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=56431"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}